SCHEMBL26527683

SCHEMBL26527683

CCOC(=O)c1c(CC)nc2nc(C)c(C)cn12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
HSD17B10 Q99714 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
MAPK1 P28482 3/20 0.45
KMT2A Q03164 2/20 0.41
RAB9A P51151 2/20 0.40
HCRTR1 O43613 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
CYP1A2 P05177 4/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2C19 P33261 3/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26527689 0.89 ALDH1A1 (0.45) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24689678 0.88 ALDH1A1 (0.46) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24689506 0.84 GABRP (0.34) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL26527746 0.82 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL23099557 0.81 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL26527673 0.80 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL23099539 0.80 ALDH1A1 (0.39) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL26527665 0.80 MAPK1 (0.50) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL23099555 0.79 KDM4E (0.45) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL23099525 0.79 KDM4E (0.45) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024089170-A1 ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2024-05-02 WO disclosed
WO-2023073090-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2023-05-04 WO disclosed